Christopher Michael James Williams

Insider Reports History

Location
London
Signature
/s/ Christopher Williams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Michael James Williams:

Company Role Class Num Shares Value Price $ Report Date Ownership
Autolus Therapeutics plc Chief Business Officer Ordinary Shares 8,198 18 Mar 2026 Direct

Insider Reports Filed by Christopher Michael James Williams

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AUTL Autolus Therapeutics plc 18 Mar 2026 0 $0 3 Chief Business Officer 18 Mar 2026, 19:48